Instytut Centrum Zdrowia Matki Polki

At Instytut Centrum Zdrowia Matki Polki in Lodz, clinical trials in hormonal diseases and nutritional and metabolic diseases focus on conditions such as type 2 diabetes, severe hypertriglyceridemia, familial chylomicronemia syndrome, and hyperlipidaemia. These studies are mainly designed to test new treatments and assess how well they control long-term metabolic risk.

• Severe hypertriglyceridemia and familial chylomicronemia syndrome research aimed at lowering dangerous lipid levels
• Type 2 diabetes and related metabolic risk management
• Hypoparathyroidism and hypophosphatasia studies exploring symptom control and disease support

This work reflects a strong interest in improving treatment options for people with chronic metabolic and endocrine disorders.

A major part of the research portfolio covers cardiovascular diseases, including atherosclerotic cardiovascular disease, heart failure, hypertension, non-obstructive hypertrophic cardiomyopathy, and inherited vascular conditions such as Marfan syndrome. The trials are focused on evaluating therapies that may reduce complications, improve heart function, and lower future cardiovascular events.

• Atherosclerotic cardiovascular disease and prevention of major cardiac events
• Heart failure and cardiomyopathy studies assessing symptom relief and function
• Marfan syndrome and related aortic disease research in children and young adults

The site’s cardiovascular studies combine prevention, treatment effectiveness, and long-term safety research across both common and rare conditions.

The clinic conducts extensive neoplasms research, especially in breast cancer, non-small cell lung cancer, small cell lung cancer, endometrial cancer, and colorectal cancer. These trials are generally aimed at testing new cancer therapies, improving response rates, and extending disease control in advanced or high-risk disease.

• Breast cancer, including HER2-positive, triple-negative, and hormone receptor-positive disease
• Non-small cell lung cancer and small cell lung cancer studies for advanced disease
• Endometrial cancer, ovarian cancer, and other solid tumor research

Research at Instytut Centrum Zdrowia Matki Polki also includes studies in lymphomas and other difficult-to-treat cancers, with a strong emphasis on better outcomes for patients with limited treatment options.

A distinctive feature of this site is its work in congenital, hereditary, and neonatal diseases and other rare disorders. Trials include Marfan syndrome, spinal muscular atrophy, Angelman syndrome, Dravet syndrome, and tuberous sclerosis complex. The overall aim is to improve care for children and families living with uncommon and often serious conditions.

• Spinal muscular atrophy and pediatric multiple sclerosis research
• Marfan syndrome and other inherited connective tissue disorders
• Rare genetic diseases such as Angelman syndrome and Dravet syndrome

These studies often explore whether emerging therapies can slow disease progression, improve function, or provide more durable symptom control in young patients.

The research program also spans immune system diseases, digestive system diseases, and hemic and lymphatic diseases. Key conditions include ulcerative colitis, Crohn's disease, chronic kidney disease, nephrotic syndrome, and atypical hemolytic uremic syndrome. These studies are designed to improve disease control, protect organ function, and evaluate longer-term treatment safety.

• Ulcerative colitis and Crohn's disease treatment research in children and adults
• Chronic kidney disease with proteinuria and iron deficiency anemia
• Atypical hemolytic uremic syndrome and other immune-mediated conditions

Across these areas, the site supports trials that aim to improve symptom remission, reduce complications, and strengthen long-term disease management.

Additional trials address nervous system diseases, eye diseases, and selected pathological conditions. Research includes multiple sclerosis, epilepsy, thyroid eye disease, and pregnancy-related conditions such as hemolytic disease of the fetus and newborn. The purpose of these studies is to improve safety, control symptoms, and support better outcomes for both patients and newborns.

• Multiple sclerosis and epilepsy studies in pediatric and adult populations
• Thyroid eye disease research focused on disease activity and function
• Hemolytic disease of the fetus and newborn trials aimed at protecting fetal and neonatal health

This broad portfolio shows the site’s commitment to both complex chronic disease research and specialized care for vulnerable patient groups.